Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Saved in:
Bibliographic Details
Title: Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).
Authors: Sater S; HAS Consulting, Miami, Florida, USA., Bifulco CB; Providence Molecular Genomics Laboratory, Portland, Oregon, USA.; Earle A Chiles Research Institute, Portland, Oregon, USA., Rodriguez-Canales J; Daiichi Sankyo Inc, Basking Ridge, New Jersey, USA., Yeong J; Department of Anatomical Pathology, Singapore General Hospital, Singapore.; Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore., Akturk G; Merck & Co Inc, Kenilworth, New Jersey, USA., Angelo M; Department of Pathology, Stanford University, Stanford, California, USA., Ballesteros-Merino C; Bristol Myers Squibb, San Diego, California, USA., Bankhead P; Edinburgh Pathology, Centre for Genomic & Experimental Medicine and CRUK Scotland Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK., Basu S; Navinci Diagnostics, Uppsala, Sweden., Blando JM; AstraZeneca, Gaithersburg, Maryland, USA., Brajkovic S; Lunaphore Technologies, Tolochenaz, Switzerland., Cassano M; Lunaphore Technologies, Tolochenaz, Switzerland., Chen BJ; Bristol Myers Squibb, Cambridge, Massachusetts, USA., Coskun AF; Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.; Emory University Winship Cancer Institute, Atlanta, Georgia, USA., Cottrell TR; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., De Andrea CE; Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.; Patología, Clinica Universidad de Navarra, Pamplona, Spain., Edwards RH; Robin H. Edwards Consulting, LLC, Newtown, Pennsylvania, USA., Egelston C; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA., Engle LL; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ernstoff MS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Fan R; Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA., Feldman M; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Fox BA; Laboratory of Molecular and Tumor Immunology, Earle A Chiles Research Institute, Portland, Oregon, USA.; Providence Cancer Institute, Portland, Oregon, USA., Galon J; INSERM, Equipe Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Paris, France., Gartrell R; Department of Oncology, Division of Pediatric Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Gnjatic S; Department of Immunology and Immunotherapy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Green BF; The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Gulley JL MD,; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Hellebust A; Indica Labs, Albuquerque, New Mexico, USA., Hewitt S; Laboratory of Pathology, National Institutes of Health, Bethesda, Maryland, USA., Hollmann TJ; Bristol Myers Squibb, Princeton, New Jersey, USA., Horn LA; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Howat WJ; Abcam, Cambridge, England, UK., Hoyt CC; Quanterix Corp, Billerica, Massachusetts, USA., Jensen SM; Laboratory of Molecular and Tumor Immunology, Earle A Chiles Research Institute, Portland, Oregon, USA.; Providence Cancer Institute, Portland, Oregon, USA., Kulasinghe A; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Lassoued W; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Lott S; Bruker Spatial Biology, San Jose, California, USA., Mansfield J; Standard BioTools, Markhan, ON, Canada., Marwitz S; Histology, Research Center Borstel - Leibniz Lung Center, Borstel, Germany.; German Center for Lung Research (DZL), Borstel, Germany., Netto G; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Page DB; Earle A Chiles Research Institute, Portland, Oregon, USA., Parra E; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Rimm DL; Departments of Pathology and Medicine (Oncology), Yale School of Medicine, New Haven, Connecticut, USA., Rodig SJ; Brigham and Women's Hospital, Boston, Massachusetts, USA., Salgado R; Department of Pathology, GasthuisZusters Antwerpen, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Schapiro D; Institute for Computational Biomedicine, Heidelberg University, Heidelberg, Germany.; Faculty of Medicine, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Translational Spatial Profiling Center (TSPC), Heidelberg, Germany., Schalper KA MD,; Departments of Pathology and Medicine (Oncology), Yale School of Medicine, New Haven, Connecticut, USA., Sunshine JC; Division of Dermatopathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Surace MJ; AstraZeneca, Gaithersburg, Maryland, USA., Szalay AS; Department of Astronomy and Physics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; The Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University, Baltimore, Maryland, USA., Thurin M; Cancer Diagnosis Program, National Cancer Institute, Bethesda, Maryland, USA., Villasboas JC; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Wharton K; Ultivue, Inc, Cambridge, Massachusetts, USA.; Roche Diagnostics Solutions, Oro Valley, Arizona, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yearley JH; Merck, Rahway, New Jersey, USA., Yuan Y; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zaki G; Biomedical Informatics and Data Science Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Ziai J; Genentech, South San Francisco, California, USA., Taube JM; Division of Dermatopathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA jtaube1@jh.edu.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Dec 21; Vol. 13 (12). Date of Electronic Publication: 2025 Dec 21.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2025-012280